Annual Working Capital
$3.03 M
-$3.00 M-49.79%
December 31, 2023
Summary
- As of February 7, 2025, ERNA annual working capital is $3.03 million, with the most recent change of -$3.00 million (-49.79%) on December 31, 2023.
- During the last 3 years, ERNA annual working capital has risen by +$4.42 million (+317.23%).
- ERNA annual working capital is now -79.95% below its all-time high of $15.09 million, reached on December 31, 2021.
Performance
ERNA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$5.22 M
+$795.00 K+13.21%
September 30, 2024
Summary
- As of February 7, 2025, ERNA quarterly working capital is -$5.22 million, with the most recent change of +$795.00 thousand (+13.21%) on September 30, 2024.
- Over the past year, ERNA quarterly working capital has dropped by -$8.25 million (-272.57%).
- ERNA quarterly working capital is now -111.80% below its all-time high of $44.26 million, reached on June 1, 2021.
Performance
ERNA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ERNA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.8% | -272.6% |
| 3 y3 years | +317.2% | -570.9% |
| 5 y5 years | +317.2% | -570.9% |
ERNA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.0% | at low | -124.3% | +13.2% |
| 5 y | 5-year | -80.0% | +317.2% | -111.8% | +13.2% |
| alltime | all time | -80.0% | +317.2% | -111.8% | +13.2% |
Eterna Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$5.22 M(-13.2%) |
| Jun 2024 | - | -$6.02 M(+275.1%) |
| Mar 2024 | - | -$1.60 M(-153.0%) |
| Dec 2023 | $3.03 M(-49.8%) | $3.03 M(-216.6%) |
| Sep 2023 | - | -$2.60 M(-20.7%) |
| Jun 2023 | - | -$3.27 M(-395.2%) |
| Mar 2023 | - | $1.11 M(-81.6%) |
| Dec 2022 | $6.03 M | $6.03 M(-28.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.38 M(-43.4%) |
| Jun 2022 | - | $14.81 M(-31.0%) |
| Mar 2022 | - | $21.45 M(+42.2%) |
| Dec 2021 | $15.09 M(-1183.2%) | - |
| Dec 2021 | - | $15.09 M(-28.8%) |
| Sep 2021 | - | $21.20 M(-52.1%) |
| Jun 2021 | - | $44.26 M(+819.8%) |
| Mar 2021 | - | $4.81 M(-445.4%) |
| Dec 2020 | -$1.39 M | -$1.39 M |
FAQ
- What is Eterna Therapeutics annual working capital?
- What is the all time high annual working capital for Eterna Therapeutics?
- What is Eterna Therapeutics annual working capital year-on-year change?
- What is Eterna Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly working capital year-on-year change?
What is Eterna Therapeutics annual working capital?
The current annual working capital of ERNA is $3.03 M
What is the all time high annual working capital for Eterna Therapeutics?
Eterna Therapeutics all-time high annual working capital is $15.09 M
What is Eterna Therapeutics annual working capital year-on-year change?
Over the past year, ERNA annual working capital has changed by -$3.00 M (-49.79%)
What is Eterna Therapeutics quarterly working capital?
The current quarterly working capital of ERNA is -$5.22 M
What is the all time high quarterly working capital for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly working capital is $44.26 M
What is Eterna Therapeutics quarterly working capital year-on-year change?
Over the past year, ERNA quarterly working capital has changed by -$8.25 M (-272.57%)